<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08435287148671</udiDi>
    <basicUdiDi>B-08435287148671</basicUdiDi>
    <tradeName>08435287148671</tradeName>
    <deviceName>ANTI-PHOSPHOLIPID IgG/IgM (APLA)</deviceName>
    <manufacturerName>BIOSYSTEMS S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000000231</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103020601</emdnCode>
    <emdnDescription>ANTI-PHOSPHOLIPID ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>44867</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T20:51:06.652Z</lastUpdated>
  </row>
  <row>
    <udiDi>04049325011618</udiDi>
    <basicUdiDi>B-04049325011618</basicUdiDi>
    <tradeName>Cholin IgG/IgM ELISA</tradeName>
    <deviceName>Cholin IgG/IgM ELISA</deviceName>
    <manufacturerName>IBL International GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000015709</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103020601</emdnCode>
    <emdnDescription>ANTI-PHOSPHOLIPID ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RE70461</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-06T00:11:15.099Z</lastUpdated>
  </row>
</eudamedExport>